Az acromegalia kezelése

Translated title of the contribution: Treatment of acromegaly

Judit Dénes, Márta Korbonits, Erika Hubina, M. Góth

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Growth hormone (GH) hypersecretion leads to acromegaly which is associated with several co-morbidities and increased mortality. Despite of the typical clinical features and modern diagnostic tools, it often takes years from the onset of the disease until the diagnosis. The aims of the treatment are to reduce or control the tumor growth, inhibit the GH hypersecretion, normalize the insulin-like growth factor-I (IGF-I) levels, treat the co-morbidities and therefore reduce mortality. There are three approaches for therapy: surgery, medical management (dopamine agonist, somatostatin analogues and GH receptor antagonist), and radiotherapy. Efficient therapy of the disease is based on the appropriate multidisciplinary team management.

Original languageHungarian
Pages (from-to)1384-1393
Number of pages10
JournalOrvosi Hetilap
Volume151
Issue number34
DOIs
Publication statusPublished - Aug 1 2010

Fingerprint

Acromegaly
Growth Hormone
Morbidity
Somatotropin Receptors
Hormone Antagonists
Mortality
Dopamine Agonists
Somatostatin
Insulin-Like Growth Factor I
Radiotherapy
Therapeutics
Growth
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dénes, J., Korbonits, M., Hubina, E., & Góth, M. (2010). Az acromegalia kezelése. Orvosi Hetilap, 151(34), 1384-1393. https://doi.org/10.1556/OH.2010.28877

Az acromegalia kezelése. / Dénes, Judit; Korbonits, Márta; Hubina, Erika; Góth, M.

In: Orvosi Hetilap, Vol. 151, No. 34, 01.08.2010, p. 1384-1393.

Research output: Contribution to journalArticle

Dénes, J, Korbonits, M, Hubina, E & Góth, M 2010, 'Az acromegalia kezelése', Orvosi Hetilap, vol. 151, no. 34, pp. 1384-1393. https://doi.org/10.1556/OH.2010.28877
Dénes J, Korbonits M, Hubina E, Góth M. Az acromegalia kezelése. Orvosi Hetilap. 2010 Aug 1;151(34):1384-1393. https://doi.org/10.1556/OH.2010.28877
Dénes, Judit ; Korbonits, Márta ; Hubina, Erika ; Góth, M. / Az acromegalia kezelése. In: Orvosi Hetilap. 2010 ; Vol. 151, No. 34. pp. 1384-1393.
@article{2747bb5c64b94dfa9d2eb7ee21b2721e,
title = "Az acromegalia kezel{\'e}se",
abstract = "Growth hormone (GH) hypersecretion leads to acromegaly which is associated with several co-morbidities and increased mortality. Despite of the typical clinical features and modern diagnostic tools, it often takes years from the onset of the disease until the diagnosis. The aims of the treatment are to reduce or control the tumor growth, inhibit the GH hypersecretion, normalize the insulin-like growth factor-I (IGF-I) levels, treat the co-morbidities and therefore reduce mortality. There are three approaches for therapy: surgery, medical management (dopamine agonist, somatostatin analogues and GH receptor antagonist), and radiotherapy. Efficient therapy of the disease is based on the appropriate multidisciplinary team management.",
keywords = "acromegaly, dopamine agonist, GH receptor antagonist, somatostatin analogues, therapy",
author = "Judit D{\'e}nes and M{\'a}rta Korbonits and Erika Hubina and M. G{\'o}th",
year = "2010",
month = "8",
day = "1",
doi = "10.1556/OH.2010.28877",
language = "Hungarian",
volume = "151",
pages = "1384--1393",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "34",

}

TY - JOUR

T1 - Az acromegalia kezelése

AU - Dénes, Judit

AU - Korbonits, Márta

AU - Hubina, Erika

AU - Góth, M.

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Growth hormone (GH) hypersecretion leads to acromegaly which is associated with several co-morbidities and increased mortality. Despite of the typical clinical features and modern diagnostic tools, it often takes years from the onset of the disease until the diagnosis. The aims of the treatment are to reduce or control the tumor growth, inhibit the GH hypersecretion, normalize the insulin-like growth factor-I (IGF-I) levels, treat the co-morbidities and therefore reduce mortality. There are three approaches for therapy: surgery, medical management (dopamine agonist, somatostatin analogues and GH receptor antagonist), and radiotherapy. Efficient therapy of the disease is based on the appropriate multidisciplinary team management.

AB - Growth hormone (GH) hypersecretion leads to acromegaly which is associated with several co-morbidities and increased mortality. Despite of the typical clinical features and modern diagnostic tools, it often takes years from the onset of the disease until the diagnosis. The aims of the treatment are to reduce or control the tumor growth, inhibit the GH hypersecretion, normalize the insulin-like growth factor-I (IGF-I) levels, treat the co-morbidities and therefore reduce mortality. There are three approaches for therapy: surgery, medical management (dopamine agonist, somatostatin analogues and GH receptor antagonist), and radiotherapy. Efficient therapy of the disease is based on the appropriate multidisciplinary team management.

KW - acromegaly

KW - dopamine agonist

KW - GH receptor antagonist

KW - somatostatin analogues

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=77955598333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955598333&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28877

DO - 10.1556/OH.2010.28877

M3 - Article

C2 - 20705553

AN - SCOPUS:77955598333

VL - 151

SP - 1384

EP - 1393

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 34

ER -